Generic Trilipix

Is a Generic Version of Trilipix Available?

Trilipix^™ (fenofibric acid delayed-release, also known as choline fibrate) is a prescription cholesterol medication. It belongs to a group of drugs known as fibrates. Trilipix is approved for the treatment of unhealthy cholesterol levels (such as high "bad" cholesterol or low "good" cholesterol) and high triglycerides.

 

This medication is manufactured by Abbott Laboratories. It is currently under the protection of a patent that prevents any generic version from being manufactured in the United States.

 

When Will a Generic Trilipex Be Available?

Currently, the patent for Trilipix is set to expire in January 2025. This is the earliest predictable date that a generic version could become available. However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for specific Trilipix uses. Once the patent expires, several companies likely will start manufacturing a generic Trilipix drug.

 

Is Trilipix the Same as Fenofibrate?

 Fenofibrate medications (Antara^™, Lofibra^™, Tricor^®, Triglide^™) have been around for a while and have patents that will expire before the Trilipix patent. These medications are similar to Trilipix, but are not exactly the same. They are not approved for use with statins, as Trilipix is. These medications are neither equivalent nor interchangeable. However, fenofibrate medications may be less expensive for some people, especially when generic fenofibrate becomes available, and may be a good alternative in some situations.